Luke Wittenburg

Associate Professor

Surgical & Radiological Sciences

Office
218 CCAH, Davis, CA 95616

Licenses
Colorado Veterinarian License
California University Veterinarian License
Education
1999, BS, New Mexico State University, Las Cruces, NM
2004, DVM, Colorado State University, Fort Collins, CO
2010, PhD, Colorado State University, Fort Collins, CO
2013, DACVCP, Colorado State University, Fort Collins, CO
2017, Certificate of Completion, University Of California, Davis, Davis, CA
Active Research Grants
Principal Investigator, Defining the role of core binding factor protein interactions in osteosarcoma, (Principal Investigator), NIH Office of Research Infrastructure Programs (ORIP)
Principal Investigator, Pharmacokinetic evaluation of intrapatient variability in doxorubicin exposure in dogs with cancer, (Principal Investigator), Center for Companion Animal Health
Principal Investigator, Safety and tolerability of a systemic doxorubicin prodrug with local hydrogel activation, (Principal Investigator), Shasqi, Inc
Co-Investigator, Pharmacokinetics of isavuconazole in healthy cats, Jonathan Dear (Principal Investigator), Center for Companion Animal Health
Most Recent Five Book Chapters
2018 Wittenburg LA, Gustafson DL: Chemotherapy of Neoplastic Diseases, Riviere JE, Papich MG, (ed), Veterinary Pharmacology and Therapeutics, Hoboken, NJ. 1191-1225.
Research Focus
Developmental Cancer TherapeuticsOsteosarcomaTranslational Cancer Research
Specialty Focus
Veterinary Clinical Pharmacology